Clinical Trials

DermatologicGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

200 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Stomach Neoplasms, Endometrial Neoplasms

NCT04620954 2021-12-01

ORION-02

31 enrolled

Carcinoma, Ovarian Epithelial

NCT05095558 2021-10-27

Microtransplantation for Ovarian Cancer

60 enrolled

Ovarian Cancer Recurrent

NCT03462212 2021-08-27

MITO25

290 enrolled

Fallopian Tube Neoplasms

NCT02785250 2021-06-18

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

85 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Recurrence

NCT04072263 2021-04-01

OVACURE

12 enrolled

Ovarian Cancer Recurrent

NCT04073680 2020-05-21

A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors

BreastGastrointestinalGynecologicHead & NeckThoracic

60 enrolled

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Endometrial Neoplasms

NCT04368273 2020-04-29

CCRT+PD-1

30 enrolled

Uterine Cervical Neoplasms

NCT04310774 2020-03-19

CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer

200 enrolled

Uterine Cervical Neoplasms

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

73 enrolled

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT04157491 2019-11-08

Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer

23 enrolled

Endometrial Neoplasms

NCT03356795 2019-09-19

Intervention of CAR-T Against Cervical Cancer

GenitourinaryGynecologic

Medullary cystic kidney disease 1, Uterine Cervical Neoplasms

NCT03362606 2019-09-19

Engineered Immune Effectors Against Ovarian Cancer

Ovarian Neoplasms

NCT03362619 2019-09-19

Engineered Immune Effectors Against Cervical Cancer

Uterine Cervical Neoplasms

NCT03699332 2019-09-13

MMIPC

GastrointestinalGynecologic

29 enrolled

Carcinoma, Gastrointestinal Neoplasms, Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT03916679 2019-04-16

MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

Ovarian Neoplasms, Recurrence

NCT03634501 2019-01-11

Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells

BreastGastrointestinalGynecologicThoracic

200 enrolled

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms

NCT01650376 2018-03-23

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

52 enrolled

Ovarian Neoplasms, Recurrence, Uterine Neoplasms

NCT02684318 2017-06-22

Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors

100 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT01600573 2016-10-11

Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)

68 enrolled

Ovarian Neoplasms

NCT02244502 2016-09-21

Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)

31 enrolled

Ovarian Neoplasms

NCT02908607 2016-09-21

Thermal Imaging for Evaluation of the Cervix

40 enrolled

Cervical Neoplasia

NCT00660101 2015-12-03

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

34 enrolled

Ovarian Neoplasms

NCT02492503 2015-07-08

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

40 enrolled

Uterine Cervical Neoplasms, Recurrence

NCT02052128 2015-06-24

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

60 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT00553683 2014-01-14

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer